Physician

Laura Ashack, M.D.

According to 2025 Medicare claims, Laura Ashack, M.D. (NPI: 1699138958) practices radiation oncology in the Kalamazoo-Portage, MI market, with the plurality of this provider's patient population coming from Kalamazoo, MI. This provider's primary affiliated billing organization is WEST MICHIGAN CANCER CENTER (NPI: 1588778484; TIN: 383061574) and primary practice location at 49007-3731.

Ashack's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 150 traditional Medicare patients, billed 1,918 HCPCS/CPT codes, and received $305,528 in Medicare payments. The top billing code was G6015 (Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session). Part D data shows 140 prescription claims across 78 beneficiaries totaling $2,502 in drug costs, led by Mometasone Furoate (Mometasone Furoate). Open Payments data shows 1 records totaling $24. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $1,175 to $2,502. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$219K$437K2021 Medicare payment: $121,720 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $437,010 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $411,230 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $305,528 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
202163700$121,720
20221832,585$437,010
20231632,413$411,230
20241501,918$305,528

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$2.9K$5.7K2016 Drug cost: $1,175 (USD; Tot_Drug_Cst)2018 Drug cost: $455 (USD; Tot_Drug_Cst)2019 Drug cost: $1,561 (USD; Tot_Drug_Cst)2021 Drug cost: $1,732 (USD; Tot_Drug_Cst)2022 Drug cost: $4,785 (USD; Tot_Drug_Cst)2023 Drug cost: $5,746 (USD; Tot_Drug_Cst)2024 Drug cost: $2,502 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/R16$1,175
2017N/RN/RN/R
20182133$455
20191542$1,561
2020N/RN/RN/R
20213462$1,732
202295190$4,785
202377166$5,746
202478140$2,502

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
G6015Intensity modulated treatment delivery, single or multiple fields/arcs,via narrow spatially and temporally modulated beams, binary, dynamic mlc, per treatment session64285$238
77334Design and construction of complex radiation treatment device40101$92
77014Ct guidance for insertion of radiation therapy fields81383$84
77336Continuing radiation therapy consultation per week48109$61
77300Calculation of radiation therapy dose45145$48

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Mometasone FuroateMometasone Furoate481,423$1,620
AlprazolamAlprazolam12100$32

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$24Novartis Pharmaceuticals Corporation
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Laura Ashack, M.D.?

Tedicare shows public-source Medicare data for Laura Ashack, M.D. (NPI 1699138958), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Laura Ashack, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Laura Ashack, M.D.?

Laura Ashack, M.D. is linked to WEST MICHIGAN CANCER CENTER (billing NPI 1588778484) in the available physician profile data.

Does Laura Ashack, M.D. have Open Payments data?

Laura Ashack, M.D. has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.